Profound Medical Corp.
PROF
$4.78
$0.061.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 38.43% | -68.30% | 5.93% | 8.04% | 9.07% |
| Total Depreciation and Amortization | 158.54% | -22.30% | -12.64% | -8.48% | 123.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -153.20% | -19.43% | -25.14% | -35.19% | -70.10% |
| Change in Net Operating Assets | -3.19% | 5,969.70% | -198.83% | 105.09% | 120.77% |
| Cash from Operations | 23.02% | -46.68% | -24.05% | 12.45% | -10.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -157.64% | -248.17% | -182.85% | -149.46% | -75.00% |
| Issuance of Common Stock | 980,200.00% | -100.00% | -99.58% | 846.68% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18,016.08% | -251.85% | -- | 850.70% | -102.84% |
| Foreign Exchange rate Adjustments | -2,015.52% | 106.41% | -105.39% | -317.81% | 243.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 474.92% | -23.12% | -91.45% | 523.63% | -2,498.71% |